Your shopping cart is currently empty

FGFR1 inhibitor-2 (with an IC50 of 4.55 μM in MDA-MB-231 cells) is a potent inhibitor of FGFR1. It is specifically useful for studying metastatic triple-negative breast cancer.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 5 mg | $970 | Inquiry | Inquiry |
| Description | FGFR1 inhibitor-2 (with an IC50 of 4.55 μM in MDA-MB-231 cells) is a potent inhibitor of FGFR1. It is specifically useful for studying metastatic triple-negative breast cancer. |
| In vitro | FGFR1 inhibitor-2, when applied at concentrations of 3 and 6 μM to MDA-MB-231 cells for a duration of 48 hours, effectively diminishes FGFR1 expression, as evidenced by Western Blot Analysis[1]. Additionally, a dose-dependent increase in the apoptotic index of MDA-MB-231 cells is observed, reaching a significant 10.6-fold elevation at a concentration of 5 μM, indicating a pronounced pro-apoptotic effect at this dosage[1]. |
| Synonyms | FGFR1 inhibitor-2 |
| Molecular Weight | 507.461 |
| Formula | C25H22F5N3O3 |
| Cas No. | 2410612-08-5 |
| Smiles | Fc1ccc(cc1)C(CCCCNC(=O)Nc1ccc(c(c1)C(F)(F)F)N(=O)=O)c1ccc(F)cc1 |
| Relative Density. | 1.350 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.